NEUROGLEE THERAPEUTICS PTE. LTD.
Last Updated: 13 Apr 2026
Neuroglee Therapeutics is a healthcare technology company dedicated to developing and commercializing software as medical treatments for patients with neurodegenerative diseases. Our innovative digital therapeutic and monitoring tools leverage best-in-class cognitive rehabilitation strategies and machine learning approaches to help preserve cognition and independence for patients, families, and clinicians. Our lead product, NG-001, is a prescription software intended for the treatment of MCI and early-stage Alzheimer's disease, and can be found at www.neuroglee.com.
Country of registration | Singapore |
Registration number | 202022023R |
Local SIC | |
Incorporation date | 29 Jul 2020 |
Company age | 5 years 10 months |
Official entity type | Private Limited Company |
No. of officers | 23 |
Contact
Address:
10 ANSON ROAD, #05-01, INTERNATIONAL PLAZA, Singapore 079903
Access Key Decision Makers
This is the legal entity page of NEUROGLEE THERAPEUTICS PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (1)
- NEUROGLEE THERAPEUTICSView MoreSingaporeNeuroglee Therapeutics is a healthcare technology company dedicated to developing and commercializing software as medical treatments for patients with neurodegenerative diseases. Our innovative digital therapeutic and monitoring tools leverage best-in-class cognitive rehabilitation strategies and machine learning approaches to help preserve cognition and independence for patients, families, and clinicians. Our lead product, NG-001, is a prescription software intended for the treatment of MCI and early-stage Alzheimer's disease, and can be found at www.neuroglee.com.
This is the legal entity page of NEUROGLEE THERAPEUTICS PTE. LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Auditor | STRATEGIC AUDIT ALLIANCE PAC |
Revenue | > 10m |
Share Capital - Ordinary shares | USD 957,245 |
Share Capital - Preference shares | USD 11,503,335 |
Last updated: 13 Apr 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of NEUROGLEE THERAPEUTICS PTE. LTD.?
- Where is NEUROGLEE THERAPEUTICS PTE. LTD.'s headquarter?
- What is NEUROGLEE THERAPEUTICS PTE. LTD.'s contact number?
- What NEUROGLEE THERAPEUTICS PTE. LTD.'s spending power?
- Does NEUROGLEE THERAPEUTICS PTE. LTD. have a presence in the domain it operates in?